GeoVax Labs, Inc.
GOVX$14M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaSMYRNA
Drugs in Pipeline
3
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Q4 2026
Market Overview
Stock performance and key metrics
GOVX News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1
COVID-19 Infection
COVID-19 Vaccine
COVID-19 Infection
Ad/PNP
Recurrent Head and Neck Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1 | Phase 2 | COVID-19 Infection | - | - |
COVID-19 Vaccine | Phase 2 | COVID-19 Infection | - | - |
Ad/PNP | Phase 2 | Recurrent Head and Neck Cancer | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply